Citius Oncology, Inc. CTOR Balance Sheet Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $2.63M-63.9% | $7.3M+85.9% | $3.92M+3,504,282% | $1120.0% | $1120.0% | ||
| —— | —— | —— | —— | —— | ||
| $84.79M+9.4% | $77.47M+11.9% | $69.22M+25.4% | $55.2M+43.3% | $38.52M+62.4% | ||
| $29.42M-20.8% | $37.15M+34.9% | $27.54M+50.4% | $18.31M+1.5% | $18.04M+5.6% | ||
| $100.7M-8.4% | $109.97M+8.9% | $100.94M+10.1% | $91.71M+0.3% | $91.44M+1.1% | ||
| $8.88M-15.0% | $10.45M-21.1% | $13.23M+52.7% | $8.67M— | —— | ||
| $58.81M+31.5% | $44.71M-9.7% | $49.49M-6.6% | $52.99M+6.5% | $49.74M+14.6% | ||
| $65.43M+26.9% | $51.56M-8.1% | $56.08M-5.5% | $59.31M— | —— | ||
| 400M0.0% | 400M0.0% | 400M0.0% | 400M+300% | 100M0.0% | ||
| -$96.18M-38.2% | -$69.57M-8.6% | -$64.04M-8.5% | -$59.04M-10.0% | -$53.67M-16.8% | ||
| $35.27M-39.6% | $58.41M+30.2% | $44.87M+38.5% | $32.4M-9.1% | $35.64M-13.7% | ||
| $100.7M-8.4% | $109.97M+8.9% | $100.94M+10.1% | $91.71M+0.3% | $91.44M+1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Citius Oncology, Inc.'s total assets?
- Citius Oncology, Inc. (CTOR) holds $100.7M in total assets, up 10.1% year over year.
- How much cash does Citius Oncology, Inc. have?
- Citius Oncology, Inc. holds $2.6M in cash and equivalents.
- Can Citius Oncology, Inc. cover its short-term obligations?
- Its current ratio is 0.50 — current liabilities exceed current assets.
- Where does Citius Oncology, Inc.'s balance sheet data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.